Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England.  Aldabergenov D, Reynolds L, Scott J, Kelleher MJ, Strang J, Copeland CS, Kalk NJ.  Int…

Managing acute opioid withdrawal with tramadol during COVID-19 lockdown in a peri-urban setting.  Bhoora U, Gloeck NR, Scheibe A.  Afr J Prim Health Care Fam Med. 2022 Sep 28;14(1):e1-e9. doi: 10.4102/phcfm.v14i1.3386. PMID: 36226932; PM…

A pilot study comparing in-person and remote outpatient substance use treatment services on quality-of-life outcomes.  Tomlinson MF, Thomas MP, Goldman B, Bourdon J, Vadhan NP.  Drug Alcohol Depend Rep. 2022 Dec;5:100108. doi: 10.1016/j…

Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers.  Sung ML, Black AC, Blevins D, Henry BF, Cates-Wessel K, Dawes MA, Drexler K, Hagle H, Molfenter T, Levin FR, Becker WC, Edelman EJ. …

Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take-home dosing during the COVID-19 pandemic.  Hallgren KA, Darnton J, Soth S, Blalock KL, Michaels A, Grekin P, Saxon AJ, Woolworth S, Ts…

Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic.  Tilhou AS, Dague L, Saloner B, Beemon D, Burns M.  JAMA Health Forum. 2022 Mar 11;3(3):e220093. doi: 10.1001/jamahealthfo…